Adaptive Biotechnologies Corp - Ordinary Shares

This stock has a reasonable momentum. Adaptive Biotechnologies Corp - Ordinary Shares is not a good growth stock. Adaptive Biotechnologies Corp - Ordinary Shares is not very popular among insiders. Adaptive Biotechnologies Corp - Ordinary Shares is a mediocre stock to choose.

News

Adaptive Biotechnologies Faces Tough Road Despite MRD Segment Growth (Rating Downgrade)

SeekingAlpha Adaptive Biotechnologies Faces Tough Road Despite MRD Segment Growth (Rating Downgrade...\n more…

Shareholders in Adaptive Biotechnologies (NASDAQ:ADPT) have lost 90%, as stock drops 7.4% this past week

Simply Wall St Research Adaptive Biotechnologies' (Nasdaq:ADPT) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.\n more…

Rothschild Investment LLC Takes Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT)

Zolmax Rothschild Investment LLC bought a new stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT - Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 10,040 shares of the...\n more…

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Sees Large Decline in Short Interest

Ticker Report Adaptive Biotechnologies Co. (NASDAQ:ADPT - Get Free Report) was the target of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling...\n more…

Adaptive Biotechnologies announces IVDR certification for clonoSEQ in EU

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Adaptive Announces IVDR Certification for clonoSEQ in European Union

Globe Newswire clonoSEQ is the first IVDR-certified test to detect minimal residual disease in patients with lymphoid malignanciesSEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation...\n more…